Vertex Provides Update on its Clinical Programs Targeting Alpha-1 Antitrypsin Deficiency

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. INTC
9. CME
10. OXM

Go back to Vertex Provides Update on its Clinical Programs Targeting Alpha-1 Antitrypsin Deficiency

Arrowhead Pharma (ARWR) Gains After Vertex Pharma (VRTX) Discontinues VX-814, Shares Up 15%

October 14, 2020 4:51 PM EDT

Arrowhead Pharma (NASDAQ: ARWR) Gains After Vertex Pharma (NASDAQ: VRTX) Discontinues VX-814, Shares Up 15%

... More